Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China · Delayed Price · Currency is CNY 13.27
-0.12 (-0.90%)
May 26, 2026, 3:00 PM CST
SHA:600161 Revenue
Beijing Tiantan Biological Products had revenue of 1.14B CNY in the quarter ending March 31, 2026, a decrease of -13.36%. This brings the company's revenue in the last twelve months to 5.99B, down -2.21% year-over-year. In the year 2025, Beijing Tiantan Biological Products had annual revenue of 6.17B with 2.26% growth.
Revenue (ttm)
5.99B
Revenue Growth
-2.21%
P/S Ratio
4.38
Revenue / Employee
1.15M
Employees
5,205
Market Cap
26.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.17B | 136.17M | 2.26% |
| Dec 31, 2024 | 6.03B | 851.42M | 16.44% |
| Dec 31, 2023 | 5.18B | 919.14M | 21.57% |
| Dec 31, 2022 | 4.26B | 149.15M | 3.63% |
| Dec 31, 2021 | 4.11B | 666.56M | 19.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Revenue RankingsBeijing Tiantan Biological Products News
- 26 days ago - Beijing Tiantan Biological Products Quarterly report: Q1 2026 - Filings
- 2 months ago - Beijing Tiantan Biological Products Annual report: H2 2025 - Filings
- 7 months ago - Beijing Tiantan Biological Products Quarterly report: Q3 2025 - Filings
- 10 months ago - Beijing Tiantan Biological Products Earnings release: H1 2025 - Filings
- 10 months ago - Beijing Tiantan Biological Products Quarterly report: H1 2025 - Filings